UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: February 13, 2023
Accession Number: 0001193125-23-028807
Submission Type: POS AM
CIK: 0001604464
Company Name: Atara Biotherapeutics, Inc.
File Number: 333-253731